Model‐based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Model‐based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus

Published:2019-03-14 Issue:6 Volume:21 Page:1381-1387
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Parkinson Joanna¹^ORCID,Tang Weifeng²^ORCID,Åstrand Magnus¹,Melin Johanna¹,Ekholm Ella³,Hamrén Bengt¹,Boulton David W.²

Affiliation:

1. Quantitative Clinical Pharmacology, Early Clinical DevelopmentIMED Biotech Unit, AstraZeneca Gothenburg Sweden

2. Quantitative Clinical Pharmacology, Early Clinical DevelopmentIMED Biotech Unit, AstraZeneca Gaithersburg Maryland, USA

3. Global Medicines DevelopmentIMED Biotech Unit, AstraZeneca Gothenburg Sweden

Funder

AstraZeneca

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13664

Reference29 articles.

1. Introduction: Standards of Medical Care in Diabetes—2018

2. Insulin-associated weight gain in diabetes – causes, effects and coping strategies

3. Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management

4. Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association

5. Increased mortality in a Danish cohort of young people with Type 1 diabetes mellitus followed for 24 years

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes;Cochrane Database of Systematic Reviews;2024-05-21

2. Effectiveness of dapagliflozin as an insulin adjunct in type 1 diabetes: a semi-mechanistic exposure-response model;Frontiers in Pharmacology;2023-10-25

3. A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes;CPT: Pharmacometrics & Systems Pharmacology;2023-03-16

4. Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients;Frontiers in Pharmacology;2023-01-04

5. Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Urine Albumin to Creatinine Ratio in Type 2 Diabetes Mellitus Patients and Medication Care;Journal of Diabetes Research;2022-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3